Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

JHS Svendgaard Laboratories Ltd.

NSE: JHS | BSE:532771

₹22.48 0.43 (1.95%) 1D

FMCG

Buy Sell

Open an Account with Bigul in 5 minutes

Performance

Today’s low

22.00

Today’s High

22.50

52W low

15.60

52W High

39.50

Open Price

22.40

Prev. Close

20.2500

Volume

191418.00

Value

4303076.64

Fundamentals

Market Cap Cr

176.20

Price to Earnings

-41.90

Price to Book Value

1.00

Dividend Yield

0.00

PE to Growth

-0.60

Op Revenue TTM Cr

73.92

Net Profit TTM Cr

-4.21

Cash From Operating Activity Cr

-9.06

Return on Equity %

-2.38

EMA & SMA

Bullish Moving Averages

14

Bearish Moving Averages

2

5Day EMA

22

10Day EMA

21.8

12Day EMA

21.7

20Day EMA

21.3

26Day EMA

21

50Day EMA

20.4

100Day EMA

21

200Day EMA

21.8

5Day SMA

21.8

10Day SMA

22

20Day SMA

21.4

30Day SMA

20.5

50Day SMA

19.4

100Day SMA

20.5

150Day SMA

23.1

200Day SMA

23

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

03 Jul, 2024

100

Week

100

Month

100

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

22.32

PIVOT

First Resistance

22.65

Second Resistance

22.81

Third Resistance

23.14

First Support

22.16

Second Support

21.83

Third Support

21.67

Relative Strength Index

65.9

Money Flow Index

83.82

MACD

0.73

MACD Signal

0.77

Average True Range

0.6

Average Directional Index

30.34

Rate of Change (21)

8.6

Rate of Change (125)

-10.97

Commodity Channel Index

113.3

Williams %R

-0.6

BETA

1 Month

0.27

3 Month

0.33

1 Year

0.63

3 Year

0.29

PRICE CHANGE ANALYSIS

↑ 1.72%

1 Week

Low

High

20.78

22.49

↑ 8.6%

1 Month

Low

High

19.82

22.49

↑ 20.86%

3 Months

Low

High

16.35

22.49

↓ -15.17%

6 Months

Low

High

15.55

39.5

↓ -1.83%

1 Year

Low

High

15.55

39.5

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 23.04 16.64 19.13 15.78 28.18 22.67 23.74 20.39 19.26 21.76 24.51
Operating Expenses Qtr 19.04 14.36 18.52 16.76 23.96 22.90 22.82 20.16 17.54 19.49 22.22
Operating Profit Qtr 2.63 -0.06 0.41 -1.99 -3.36 -1.65 -1.97 -0.95 -0.29 -0.15 0.84
EBIDT Qtr Cr 4.00 2.28 0.60 -0.97 -14.41 -0.24 0.92 0.23 1.72 2.27 2.29
Depreciation Qtr 3.69 1.62 1.50 1.28 1.57 1.41 1.44 1.41 1.44 1.50 1.51
Net Profit Qtr -0.75 0.01 -0.73 -1.94 -9.44 -1.79 -0.59 -3.32 -3.67 0.46 0.45
Basic EPS Qtr -0.10 0.00 -0.09 -0.30 -1.45 -0.28 -0.09 -0.51 -0.57 0.07 0.12
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 75.11 94.98 88.05 102.51 144.71
Operating Expenses Annual Cr 71.73 89.84 79.73 93.30 123.49
Operating Profit Annual -0.93 -7.93 0.18 3.67 9.47
Operating Profit Margin Annual % -1.24 -8.35 0.20 3.58 6.54
Total Expenses Annual Cr 78.53 96.07 86.13 99.31 132.28
EBIDT Annual Cr 3.38 5.14 8.32 9.21 21.22
EBIDT Annual margin % 4.51 5.41 9.45 8.99 14.66
Depreciation 6.35 5.82 5.90 5.56 7.43
PAT Before ExtraOrdinary Items Annual Cr -4.05 -15.14 -2.44 2.77 1.77
Net Profit Annual -4.05 -15.14 -2.44 2.77 1.77
Basic EPS Annual -0.52 -2.33 -0.38 0.45 0.29
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 170.28 174.82 189.77 191.48 181.50
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 3.83 4.06 4.72 3.24 3.26
Total Current Liabilities Annual Cr 23.33 34.53 16.60 19.76 44.33
Total Capital Plus Liabilities Annual Cr 197.45 213.41 211.09 214.48 229.09
Fixed Assets Annual 89.77 68.04 71.24 67.54 64.81
Total Non Current Assets Annual 154.03 107.23 126.37 113.01 114.13
Total Current Assets Annual 43.42 106.18 84.72 101.47 114.96
Total Assets Annual 197.45 213.41 211.09 214.48 229.09
Contingent Liabilities plus Commitments Annual Cr - 0.94 5.83 6.20 2.87
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual -8.58 20.21 -11.28 15.42 15.14
Cash from Investing Activity Annual -21.95 9.14 -0.96 -5.58 -6.76
Cash from Financing Annual Activity 2.17 -0.79 0.02 6.42 -8.45
Net Cash Flow Annual - 28.56 -12.22 16.26 -0.07
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 21.72 26.94 29.24 29.73 29.80
ROE Annual % -2.37 -8.66 -1.28 1.44 0.97
ROCE Annual % -1.70 -0.38 1.24 1.87 7.46
Total Debt to Total Equity Annual 0.02 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 4.78 6.26 10.41 9.50 15.95
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 23.04 16.64 19.13 20.37 33.21 27.12 27.49 22.79 21.49 23.65 26.33
Operating Expenses Qtr 20.83 14.36 18.52 22.05 28.25 27.29 26.54 22.77 19.26 22.05 23.50
Operating Profit Qtr 0.84 -0.06 0.41 -3.02 -2.85 -1.84 -2.49 -1.46 -0.15 -1.13 1.14
EBIDT Qtr Cr 2.21 2.28 0.60 -1.69 -13.67 -0.17 0.95 0.02 2.23 1.60 2.83
Depreciation Qtr 1.90 1.62 1.50 1.74 2.31 1.71 1.74 1.70 1.69 1.71 1.86
Net Profit Qtr -0.75 0.01 -0.73 -2.74 -9.87 -1.53 -0.22 -4.16 -4.34 0.27 0.47
Basic EPS Qtr -0.10 0.00 -0.09 -0.40 -1.52 -0.24 -0.03 -0.59 -0.68 -0.04 0.05
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 75.11 110.60 95.64 108.31 152.95
Operating Expenses Annual Cr 71.74 105.31 87.09 98.85 137.44
Operating Profit Annual -0.94 -9.10 -0.84 1.92 1.67
Operating Profit Margin Annual % -1.25 -8.23 -0.88 1.77 1.09
Total Expenses Annual Cr 78.54 113.81 95.54 107.34 148.16
EBIDT Annual Cr 3.38 5.30 8.55 9.46 15.51
EBIDT Annual margin % 4.50 4.79 8.94 8.74 10.14
Depreciation 6.35 7.46 7.05 7.25 8.76
PAT Before ExtraOrdinary Items Annual Cr -4.06 -16.78 -4.29 1.34 -4.86
Net Profit Annual -4.06 -15.46 -4.05 1.20 -1.98
Basic EPS Annual -0.52 -2.34 -0.63 0.20 -0.32
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 169.88 172.44 185.90 188.70 178.00
Minority Interest Liability Annual Cr 0.00 7.87 9.14 9.27 6.60
Total Non Current Liabilities Annual Cr 3.83 17.83 8.04 6.87 7.87
Total Current Liabilities Annual Cr 23.34 38.05 18.91 23.13 48.45
Total Capital Plus Liabilities Annual Cr 197.05 236.19 221.99 227.96 240.92
Fixed Assets Annual 88.97 73.66 77.37 71.03 71.58
Total Non Current Assets Annual 153.39 146.26 143.04 107.01 110.69
Total Current Assets Annual 43.66 89.93 78.95 120.95 130.22
Total Assets Annual 197.05 236.19 221.99 227.96 240.92
Contingent Liabilities plus Commitments Annual Cr - 0.99 4.93 8.64 3.11
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual -9.06 18.90 -9.14 12.03 10.35
Cash from Investing Activity Annual -21.26 6.23 -4.70 -2.23 -10.97
Cash from Financing Annual Activity 2.17 8.10 -1.67 10.31 0.49
Net Cash Flow Annual - 33.23 -15.50 20.11 -0.13
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 21.67 27.78 30.05 30.74 30.31
ROE Annual % -2.38 -8.96 -2.17 0.63 -1.11
ROCE Annual % -1.70 -1.09 0.73 1.07 3.50
Total Debt to Total Equity Annual 0.02 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 4.77 5.50 9.91 9.39 11.14
Name Holding Percent Holding Id Pledged % Locked %
ASPIRE EMERGING FUND 1.91 74504160 - -
Name Holding Percent Holding Id Pledged % Locked %
NIKHIL NANDA 33.79 74504151 0 1.89
SUSHMA NANDA 3.91 74504152 0 0
Name Holding Percent Holding Id
ASPIRE EMERGING FUND 1.91 74504160
SIXTH SENSE INDIA OPPORTUNITIES II 6.21 74504157
Name Holding Percent Holding Id
VIJAY MOHAN GOVILA 3.05 74504169
HUF 2.15 74504162
PARKER MULTI COMMODITIES 2.05 74504165
ZAVERI FINSTOCK PRIVATE LIMITED 1.32 74504166
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Dec 26, 2011 0.75 FINAL - Equity Share
Dec 22, 2010 0.5 FINAL - Equity Share
Sep 10, 2009 0.25 FINAL - Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
Jun 04, 2024 Preferential issue of shares -
May 18, 2024 Audited Results -
Feb 14, 2024 Quarterly Results -
Nov 07, 2023 Quarterly Results -
Aug 14, 2023 Quarterly Results -
May 30, 2023 Audited Results -
Feb 14, 2023 Quarterly Results -
Nov 10, 2022 Quarterly Results -
Aug 09, 2022 Quarterly Results -
May 27, 2022 Audited Results (Revised)
Feb 08, 2022 Quarterly Results -
Nov 02, 2021 Quarterly Results -
Aug 10, 2021 Quarterly Results -
Jun 22, 2021 Audited Results -
Feb 09, 2021 Quarterly Results -
Nov 03, 2020 Quarterly Results -
Sep 15, 2020 Quarterly Results -
Jun 23, 2020 Audited Results -
Feb 11, 2020 Quarterly Results -
Nov 12, 2019 Quarterly Results -
Aug 06, 2019 Quarterly Results -
May 18, 2019 Audited Results -
Feb 12, 2019 Quarterly Results -
Oct 30, 2018 Quarterly Results -
Aug 14, 2018 Quarterly Results -
May 15, 2018 Audited Results -
Mar 27, 2018 Others To invest the funds of the Company in its Subsidiary Companies through subscription of equity shares.
Jan 30, 2018 Quarterly Results -
Dec 25, 2017 Others To invest the funds of the company in its Subsidiary Company i.e. JHS Svendgaard Brands Limited, through subscription of equity shares.
Nov 21, 2017 Quarterly Results -
Aug 29, 2017 Quarterly Results -
May 23, 2017 Audited Results -
Feb 13, 2017 Quarterly Results -
Oct 27, 2016 Quarterly Results -
Aug 02, 2016 Quarterly Results (Revised from 30/07/2016)
May 26, 2016 Audited Results & Others For consideration of conversion of Fully Convertible Warrants into Equity Shares to the respective allottees.
Mar 03, 2016 Others Consider of conversion of Fully Convertible Warrants into Equity Shares to the respective allottees.
Feb 11, 2016 Quarterly Results Mr. Mohit Dahiya, Company Secretary of M/s. Mohit & Associates, Company Secretaries has been appointed as Secretarial Auditors of the Company for the financial year 2015-16.
Jan 05, 2016 Allotment of Warrants The Board has considered and approved part conversion of aforesaid Warrants, to the extent of 32,80,000 Warrants into equivalent no. of Equity Shares of face value of Rs. 10/- each.
Nov 10, 2015 Quarterly Results -
Aug 13, 2015 Quarterly Results -
Jul 28, 2015 Preferential Issue To consider the issuance of convertible warrants on preferential basis.
Jul 14, 2015 Audited, Quarterly Results & Dividend Revised from 08/07/2015
Jul 02, 2015 Preferential Basis To issue fully convertible warrants/equity shares to promoters and non-promoters on a preferential basis subject to approval in the general meeting.
May 05, 2015 Quarterly Results -
Apr 28, 2015 Quarterly Results -
Apr 13, 2015 Appointment & Resignation of Secretary -
Feb 14, 2015 Quarterly Results -
Feb 05, 2015 To Consider selling or Dispose-off To relook the proposal of ongoing Pref Allotment of Equity Shares to the persons belonging to the Promoter & Non-Promoter Group in respect of which shareholders approval.(Adjourned from 29/01/2015)
Nov 22, 2014 Quarterly Results Revised from 15/11/2014
Aug 21, 2014 Quarterly Results (Revised)
May 30, 2014 Audited Results & Dividend -
Feb 12, 2014 Quarterly Results -
Nov 12, 2013 Quarterly Results -
Aug 14, 2013 Quarterly Results -
May 27, 2013 Audited Results & Dividend -
Feb 11, 2013 Quarterly Results -
Nov 06, 2012 Quarterly Results -
Aug 14, 2012 Quarterly Results -
May 26, 2012 Audited Results & Dividend -
Mar 31, 2012 To consider the Preferential Allotment For allotment of 5,00,000 Equity Shares on preferential basis to Mr. Nikhil Nanda @ Rs.97.75, the person belonging to Promoter and Promoter Group of the Company.
Feb 11, 2012 Quarterly Results -
Jan 07, 2012 Others The Board has appointed Mr. Tarun Chhabra as Company Secretary & Compliance Officer of the Co., who has assumed the charge with effect from January 07, 2012 in place of Mr. Anshu Kumar Chakravoarty.
Dec 02, 2011 Audited Results Inter alia, to consider and take on record the Audited Financial Results for the financial year ended on March 31, 2011.
Nov 28, 2011 Final Dividend -
Nov 14, 2011 Quarterly Results -
Aug 11, 2011 Quarterly Results -
May 14, 2011 Quarterly Results -
Mar 12, 2011 To consider the issue of Equity Shares To consider the issue of Equity Shares of the Company to Foreign Venture Capital Investor (FVCI) on a preferential basis.
Feb 08, 2011 Quarterly Results -
Feb 05, 2011 Issue of Global Depository Receipts Inter alia, to consider the issue of GDR's, ADRs, FCCBs or any combination of Securities to any person including foreign / resident investors.
Nov 09, 2010 Quarterly Results -
Aug 14, 2010 Quarterly Results -
Jul 07, 2010 Scheme of Amalgamation The Board has approved the Scheme of Amalgamation of the JHS Svendgaard Hygiene Products Ltd., Wave Hygiene Products with the Co. JHS Svendgaard Laboratories Ltd. & the valuation report thereof.
May 29, 2010 Audited Results & Final Dividend -
Mar 30, 2010 Scheme of Amalgamation To consolidate the businesses of two group entities, JHS Svendgaard Hygiene Products Ltd. & Waves Hygiene Products into the Co. through a SoA under sections 391 - 394 of the Co's Act, 1956.
Jan 30, 2010 Quarterly Results -
Oct 31, 2009 Quarterly Results -
Sep 25, 2009 Allotment of Equity Shares The Company has allotted 1550000 equity shares for Conversion of the Warrants.
Aug 13, 2009 Allotment of Warrants The Board decided to allot 11,00,000 Warrants which will be convertible into Equity Shares at the option of the holders, to the persons belonging to the Promoter and strategic investors.
Jul 31, 2009 Quarterly Results -
Jun 30, 2009 Audited Results & Dividend To recommend a dividend of Rs. 0.25 per share on Equity shares for the financial year 2008-09.
Jan 16, 2009 Quarterly Results -
Oct 31, 2008 Quarterly Results & Others To accept resignation of Mr. Naveen Breja the Director of the Company & to appoint Mr. Puneet Kumar Manglik as the Additional Director of Company.
Jul 31, 2008 Quarterly Results -
Jun 19, 2008 Audited Results -
Mar 26, 2008 Allotment of equity shares/warrants -
Jan 29, 2008 Quarterly Results -
Oct 31, 2007 Quarterly Results -
Jul 31, 2007 Quarterly Results -
Jun 29, 2007 Audited Results -
Jan 15, 2007 Quarterly Results -
Ex-Date Bonus Ratio Record Date
Bigul
24 Jun 2024

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement Under Regulation 30 Of SEBI(LODR) Regulations, 2015 Regarding The Intimation Of Trading Approval Of JHS Svendgaard Retail Ventures Limited.

 Intimation of receipt of Trading Approval from the JHS Svendgaard Retail Ventures Limited.
Bigul
24 Jun 2024

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Closure of Trading Window

 Intimation of Closure of Trading window for the quarter ended 30th June, 2024.
Bigul
21 Jun 2024

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Intimation Regarding The Expansion Of The Company Business Operations.

 In reference to the Regulation 30 of SEBI(LODR) Regulations, 2015, the company wish to inform you that the company decided to expand its business operation in Union Territory, Jammu & Kashmir.
Bigul
15 Jun 2024

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

 JHS SVENDGAARD LABORATORIES LIMITED informed the Exchange regarding the Appointment of M/s Lodha & Co LLP, Chartered Accountant as a Statutory Auditor of the Company.
Bigul
12 Jun 2024

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Publication of Notice of Extra-Ordinary General Meeting to be held on 04th July, 2024.
Bigul
10 Jun 2024

JHS SVENDGAARD LABORATORIES LTD. - 532771 - JHS SVENDGAARD LABORATORIES LIMITED Has Informed The Exchange About Notice Of Shareholders Meeting For Extra-Ordinary Meeting To Be Held On 04-Jul-2024.

 JHS SVENDGAARD LABORATORIES LIMITED has informed the Exchange about Notice of Shareholders Meeting for Extra-ordinary Meeting to be held on 04-Jul-2024.
Bigul
04 Jun 2024

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Preferential Issue

 The Board in its meeting held today approved Preferential issue of Equity shares & warrants.
Bigul
04 Jun 2024

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Board Meeting Outcome for PREFERENTIAL ISSUE OF EQUITY SHARES & WARRANTS

 THE BOARD IN ITS MEEETING APPROVED PREF ISSUE OF EQUITY SHARES & WARRANTS
Bigul
30 May 2024

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Board Meeting Intimation for To Consider And Approve The Proposal Of Raising Of Funds By Way Of Issue Of One Or More Instruments.

 JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/06/2024 ,inter alia, to consider and approve To consider and approve the proposal of raising of funds by way of issue of one or more instruments
Bigul
30 May 2024

JHS SVENDGAARD LABORATORIES LTD. - 532771 - Closure of Trading Window

 Intimation of closure of trading window
See all News

FAQs

The latest market price of JHS Svendgaard Laboratories Ltd. on NSE was Rs. 22.48 as of today.

The opening share price of JHS Svendgaard Laboratories Ltd. was Rs. 22.40 as of today.

The 52-week high share price of JHS Svendgaard Laboratories Ltd. was Rs. 39.50.

The 52 week low share price of JHS Svendgaard Laboratories Ltd. was Rs. 15.60.

JHS Svendgaard Laboratories Ltd. has a market cap of Rs. 176.20 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of JHS Svendgaard Laboratories Ltd. is -0.60. Please refer to the Fundamentals section for further details.

The operating revenue for JHS Svendgaard Laboratories Ltd. in the last FY was Rs.  73.92 crore. Please refer to the Financials section for further details.

The Net Profit for JHS Svendgaard Laboratories Ltd. in the last FY was Rs. -4.21 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by JHS Svendgaard Laboratories Ltd. was on 2011-12-26 for Rs. 0.75 per share. According to today’s share price, the dividend yield of JHS Svendgaard Laboratories Ltd. stands at 0.00. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about JHS Svendgaard Laboratories Ltd..

Close

Let's Open Free Demat Account